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The human cell surface protein CD46 is the main measles virus (MV) receptor. We analyzed the CD46 isoforms expressed
in the brain of three patients who died with persistent MV infections and in an unaffected brain. Complete CD46 cDNAs
were produced and found to code exclusively for CD46 isoforms with cytoplasmic tail 2. Selective expression of tail 2
isoforms was shown in a second control brain by Western blots with antibodies specific for each of the cytoplasmic tails.
Binding of purified MV particles and virus-dependent cell fusion were tested after transient expression of brain-derived
CD46 proteins in mouse cells. All the brain-derived proteins mediated MV binding and virus-dependent fusion. Isoforms
containing both serine/threonine/proline (STP)-rich domains were more active in virus binding, whereas isoforms with only
one STP domain were more efficient in mediating fusion. q 1996 Academic Press, Inc.
INTRODUCTION review see Liszewski et al., 1991), is expressed in four
major isoforms in nearly every cell type. These isoforms
Acute measles virus (MV) infections start in the respi-
(BC1, BC2, C1, and C2), which arise from alternative
ratory tract from where the virus spreads to local lym-
splicing, differ in the number of O-linked, oligosaccha-
phatic tissues (Griffin et al., 1994). During secondary vire-
ride-rich serine/threonine/proline (STP) domains (B, C)
mia the infection disseminates in many tissues including
and in having one of two alternative cytoplasmic tails
brain endothelial cells (Esolen et al., 1995), and recently
(tail 1, tail 2). All isoforms contain four short consensus
MV mRNA was detected in each fifth brain autopsy (Ka-
repeats (SCR), each about 60 amino acids in length, a
tayama et al., 1995). High amounts of MV RNAs and
short region of unknown function, and are functional as
antigens, however, are detected only in neurons and glial
MV receptors (Manchester et al., 1994; Iwata et al., 1994;
cells of victims of subacute sclerosing panencephalitis
Gerlier et al., 1994). Information on the CD46 isoforms
(SSPE) or measles inclusion body encephalitis (MIBE),
expressed in human brain is available (Johnstone et al.,
rare diseases which occur years after acute infection
1993), but no study has been performed on the brain
(Baczko et al., 1986, 1988; Cattaneo et al., 1987; Haase
of patients who died with persistent MV infections. We
et al., 1985). How MV initially passes the blood–brain
analyzed CD46 expression in the brains of three patients
barrier is unclear, but at the final disease stage only cell-
who died from SSPE or MIBE, and from a control brain,
associated viruses defective in the envelope proteins
by cloning complete cDNAs and assaying the corre-
matrix, fusion (F), and hemagglutinin (H) are detected (for
sponding proteins for their function as MV receptors.
review see Wechsler and Meissner, 1982; Billeter and
Cattaneo, 1991). Spreading of defective MVs through the MATERIALS AND METHODS
brain is thought to occur by F/H-induced cell–cell fusion
Autopsy tissue(Cattaneo and Rose, 1993; Billeter et al., 1994).
A host protein required for F/H-induced cell fusion and Brain autopsy material from three individuals (A, B, and
for viral entry is the MV receptor CD46 (Do¨rig et al., 1993; C) who died of persistent measles infections (Cattaneo
Naniche et al., 1993; for review see Gerlier et al., 1995). et al., 1987) and from an unaffected brain (D) were used
It is assumed that the H protein binds to CD46, mediating for RNA preparation. Brain autopsy samples (cerebellum,
the formation of contacts between virus and host cell. cortex, and hippocampus) from a second unaffected indi-
CD46, a type I transmembrane protein which belongs to vidual (E) were used for protein detection.
the RCA family (regulators of complement activation; for
Antibodies, cells, and viruses
Antisera specific for the CD46 cytoplasmic tail 1 and1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 41-1-371 7205. tail 2 were raised in rabbits against peptides correspond-
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ing to the carboxyl-terminal region of each of the two buffered saline (PBS)] as a 10% homogenate. Cell ex-
tracts were separated on polyacrylamide gels and trans-alternative tails (tail 1, NH2-(C)TDETHREVKFTSL; tail 2,
NH2-(C)TYQTKSTTPAEQRG). A cysteine was attached to ferred to polyvinyldifluoride membranes (Millipore). Anti-
bodies were detected using the ECL system (Amersham).the amino terminus of the peptide to allow coupling to
keyhole limpet hemocyanin.
MV binding assay and flow cytometric analysisMouse Ltk0 cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal The MV binding assays were basically performed as
calf serum (FCS). The Halle´ strain of measles virus was previously described (Naniche et al., 1993). Briefly,
grown and purified as described previously (Naniche et cells were detached from six-well dishes 18 hr after
al., 1993). Recombinant vaccinia viruses were grown on transfection by washing with PBS/EDTA. Cells (21 105)
BHK cells. The vaccinia virus coding for measles F and were then incubated with sucrose gradient-purified MV
H proteins (VV-F/H) was kindly provided by R. Drillien particles at room temperature for 1 hr in DMEM supple-
(Wild et al., 1992). The vaccinia virus vTF7-3 coding for mented with 6% FCS and 0.05% NaN3 , washed twice,bacteriophage T7 RNA polymerase was kindly provided and then incubated with a H-specific monoclonal anti-
by B. Moss (Fuerst et al., 1986). body for 30 min (cI55; Giraudon and Wild, 1985). The
monoclonal antibody was detected with a phycoer-Cloning of CD46 cDNAs and determination of their
ythrin-conjugated anti-mouse antibody in a FACScancoding capacity
(Becton – Dickinson). To calculate binding efficiencies
Total RNA from HeLa cells and from brains of individu- the mean fluorescence was normalized to CD46 sur-
als A–D was reverse transcribed using a primer comple- face expression which was determined in parallel us-
mentary to the last nucleotides of the CD46 coding se- ing the CD46-specific monoclonal antibody MCI 20.6
quence (5* GATCTAGAATTCAGCCTCTCTGCTCTGC- (Naniche et al., 1993).
TGGAGTGGT; an added EcoRI site is shown in italics,
Cell–cell fusion assaynucleotides complementary to the stop codon in exon 14
are underlined). The cDNAs were amplified by PCR using
Four hours after transfection about 8 1 105 cells were
an additional primer corresponding to the first nucleo-
detached with PBS/EDTA and cocultivated with an equiv-
tides of the CD46 coding region (5* ATATCGATACAT-
alent amount of Ltk0 cells infected with 10 PFU of VV-F/
ATGGAGCCTCCCGGCCGCCGCGA; an added ClaI site
H per cell. Formation of syncytia was monitored 15 hr
is shown in italics, the initiation codon is underlined),
after starting the cocultivation. The fusion efficiency
digested with ClaI and EcoRI, and cloned into the corre-
was determined by counting nuclei in syncytia and total
sponding sites of vector pBluescript (SK). The isoforms
nuclei.
encoded by the cDNAs were defined by restriction analy-
sis and where necessary also by sequencing. The re-
RESULTSstriction analysis was based on digestion with BamHI
(three sites in CD46 cDNAs) and on restriction enzymes Only tail 2 CD46 isoforms are found in brain
diagnostic for the alternatively spliced exons: SalI (exon
The brain autopsy material used for our studies was8, corresponding to STP B), StuI (exon 9, corresponding
derived from two SSPE cases (A and B), a MIBE caseto STP C), and DdeI (exon 13, corresponding to tail 1).
(C) (Cattaneo et al., 1987), and two control individuals (DFor part of the expression studies, the CD46 inserts were
and E). Total RNA was purified from autopsy material ofsubcloned into vector pRc/CMV (Invitrogen).
individuals A–D, cDNA generated, amplified, and cloned
into an eucaryotic expression vector. As a control,Expression of CD46
CD46-specific cDNA was generated from HeLa cell-de-
The CD46 cDNAs were expressed in mouse Ltk0 cells rived RNA.
using the vaccinia virus T7 expression system (Fuerst et From HeLa cells, clones of all four major isoforms
al., 1986). About 106 cells were infected with 107 PFU of were obtained, confirming the validity of our approach
vTF7-3 and then transfected with 3 mg plasmid DNA us- (Table 1). In contrast, from the four brains only clones
ing 8 ml lipofectin (GIBCO). Cells were harvested 18 hr coding for tail 2 isoforms were obtained. The assignment
after transfection to control expression levels by Western of the clones was verified by expression of the corre-
blot and flow cytometric analysis. sponding proteins in mouse Ltk0 cells using the vaccinia
virus T7 expression system. From these cells cyto-
Cell extracts and Western blot analysis
plasmic extracts were prepared and analyzed by Western
blotting using a rabbit anti-CD46 serum.For Western blot analysis cytoplasmic cell extracts
were prepared as previously described (Buchholz et al., Lanes 1–4 of Fig. 1 show the four CD46 isoforms
obtained from HeLa cells (negative control in lane 5). A1993). Brain autopsy material was solubilized in lysis
buffer [0.5% NP-40, 0.5% Na-deoxycholate in phosphate- broad upper band, migrating differently for BC isoforms
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TABLE 1 (stop). Among these, a 26-amino-acid-long hydropho-
bic strech (shown in italics) surrounded by chargedIsoforms Encoded by CD46 cDNA Clones
residues is noteworthy because it might serve as a
Number of cDNA clones transmembrane domain.
Clone 92 has a deletion of eight nucleotides resulting
Source BC1 BC2 C1 C2 in a change of the predicted protein sequence toward the
end (position 21) of the transmembrane region: VIC*V21/HeLa cells 4 5 6 1
EISSKEEEE*RQSR(stop). The CD46 protein encoded byBrain A (SSPE) — 1 — 8
Brain B (SSPE) — 3 — 1 this clone should insert into the membrane properly but
Brain C (MIBE) — 2 — — has a novel, 13-amino-acid-long, highly charged cyto-
Brain D (control) — — — 4 plasmic domain. It is noteworthy that O-glycosylation of
this protein is inefficient (lane 7).
We did not obtain further clones of these types, indicat-
compared to C isoforms, and a distinct lower band mi- ing that these mutations are not found in genomic DNA.
grating between 47 and 49 kDa, depending on the iso- Furthermore, both sequence alterations are not located
form, are visible. The upper band is composed of proteins at exon/intron boundaries and thus cannot arise by alter-
heterogeneous in the amount of O-glycosylation of the native splicing. We thus assume that those cDNAs re-
STP domains (Liszewski et al., 1991). BC isoforms (lanes sulted from errors of the reverse transcriptase or of the
1, 3) are more heavily O-glycosylated and migrate at 58– polymerase used for amplification. Nevertheless, both
70 kDa, whereas C isoforms migrate at 55–60 kDa (lanes clones were further analyzed and found to encode func-
2, 4). The lower band corresponds to a precursor mole- tional MV receptors (see below).
cule which bears N-linked but no O-linked oligosaccha- The cDNA analysis suggested that tail 2-containing
rides (Post et al., 1991). isoforms predominate in the brains of one unaffected
The migration pattern of most brain-derived CD46 and of the three SSPE/MIBE patients. To validate these
proteins was consistent with the classification based data on the protein level we raised antisera against pep-
on the DNA analysis (Fig. 1, lanes 6 – 15). However, tides corresponding to the carboxyl-terminal region of
two clones (73 and 92) expected to code for proteins each of the two alternative tails. The CD46 protein ex-
of the C2 isoform produced proteins migrating faster pression pattern was then analyzed in three brain re-
than expected (Fig. 1, lanes 7, 12). Sequence analysis gions (cerebellum, cortex, and hyppocampus) of a sec-
of clone 73 revealed the deletion of an A residue within ond MV unaffected individual.
a stretch of 7 As. This deletion results in a change in Figure 2 (A and B) shows a quantitative Western blot
the predicted protein sequence. The altered sequence analysis of the CD46 isoforms present in the cerebellum
starts after the eighteenth amino acid of SCR IV and
contains the following 74 amino acids: (FGK)18NF*TTK-
QQLCLNA*IRVFTSMAAT*QLSVTVTVLG*IPQFQSVL-
KV*LGLLTSL QSQ* I IQDILNLRK*EYLTVWMFG S*LL
FIG. 2. Western blot analysis of a human brain extract using tail-1
(A) and tail-2 (B) specific antisera. Analysis of a cerebellum homogenate
from brain E is shown. The preparation of the homogenate is described
under Materials and Methods. To obtain standard proteins, mouse Ltk0
cells were programmed to express CD46 of the C1 or C2 isoforms.
The concentration of both standards was determined using a polyclonal
antiserum by Western blotting. Equivalent amounts of the two standards
were diluted 1:3 six consecutive times. Each of the dilutions was mixedFIG. 1. Expression analysis of 14 CD46 clones from different sources.
Clones representing each of the major isoforms of CD46 obtained from with 80 mg of the brain homogenate and the mixtures were separated
on a 10% SDS–polyacrylamide gel (lanes 3–8). Pure brain homogenateHeLa cells (lanes 1–4) and clones obtained from human brains (lanes
6– 15) were produced in mouse Ltk0 cells using the vTF3-7 expression (80 mg) was loaded on lane 9. As a negative control a mouse brain
extract (lane 2) and as positive controls the cell extracts containing thesystem. Twenty hours after transfection, cells were harvested and cyto-
plasmic extracts prepared. Cell extracts were separated on a 10% SDS– standards were used (CD46-C1, panel A, lane 1, and CD46-C2, panel
B, lane 1). Signals from proteins migrating with an apparent molecularpolyacrylamide gel and analyzed by Western blotting using a rabbit
anti-CD46 serum. Extracts from untransfected cells were used as a weight below 40 kDa are probably due to cross-reactions. (C-less CD46
isoforms should migrate at 45–47 kDa.) Arrows indicate the positionscontrol (lane 5). The asterisk indicates a frameshift mutation in the
corresponding clone. of the C1 or C2 isoforms, respectively.
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FIG. 3. Flow cytometric analysis of cell surface expression and virus binding of a CD46 isoform. A CD46 cDNA of the C2 type (HeLa clone 2)
was expressed in Ltk0 cells using the vTF7-3 system. As a negative control, cells were transfected with a plasmid containing the CD46 open
reading frame in reverse orientation. About 8 1 105 cells were split into four aliquots. The first aliquot was used to measure surface expression of
CD46 using the monoclonal anti-CD46 antibody 20.6 (anti CD46, left panels, shaded profiles). The second aliquot was incubated with purified MV,
and bound viral particles were detected with the cI55 anti-H monoclonal antibody (right panels, shaded profiles). As controls, the third aliquot was
incubated only with the second antibody (open profiles in the left panels), and the fourth aliquot with cI55 and the second antibody but without
virus (open profiles in the right panels).
homogenate. Lane 9 contains the pure homogenate, isoform derived from HeLa cells (bottom panels). In con-
trol experiments (top panels) a slight increase in antiwhereas in lanes 3–8 decreasing amounts of CD46 stan-
dard extracts mixed with the brain material were loaded. H-dependent fluorescence was monitored in Ltk0 cells
incubated with MV particles (mean value 12, top rightThe blot of Fig. 2A was probed with tail 1 antiserum and
the blot of Fig. 2B with tail 2 antiserum. Endogenous panel, shaded surface), indicating that some CD46-inde-
pendent MV binding occurred as previously observedCD46 protein (lanes 9, arrowheads) was detected only
with the tail 2 antiserum. This protein migrates with the (Naniche et al., 1993). However, when these cells ex-
pressed CD46, a significant increase in MV binding wassame mobility as the C2 isoform used as a standard and
obscures the C2 standard signal beginning from the 1:27 observed (mean value 208, bottom right panel, shaded
surface), yielding a profile that reflected the CD46 expres-dilution (Fig. 2B, lane 5), whereas the C1 standard was
detected up to the 1:243 dilution (Fig. 2A, lane 7). Thus sion profile (bottom left panel, shaded surface). We note
that two cell populations with different expression levelsthe concentration of tail 2 protein in that brain is at least
nine times higher than that of tail 1 protein, a result in were reproducibly detected with all cDNAs expressed.
Surface expression and MV binding levels were deter-line with the cloning of 17 tail 2 and no tail 1 cDNAs from
other brains. The C2 isoform, but no tail 1-containing mined for all 14 clones presented in Fig. 1 and are sum-
marized in Table 2. The different isoforms were ex-isoforms, was also detected in the cortex and hippocam-
pus of the same patient (data not shown). Taken together, pressed at the cell surface with an efficiency ranging
between 55 and 150%, when normalized to the surfacethese results confirm that exon 13, coding for the cyto-
expression of the BC1 isoform. The two proteins derivedplasmic tail 1, is preferentially spliced out in brain cells
from mutant cDNAs 73 and 92, however, had lower cell(Johnstone et al., 1993).
surface expression levels (30 and 50%, respectively).
All the CD46 proteins bound MV particles. In TableThe CD46 isoforms expressed in brain are functional
2 their respective binding efficiency, defined as virusas MV receptors
binding divided by CD46 surface expression, is shown.
We then analyzed the ability of the brain-derived CD46 Considering the experimental error (5 – 30% variability),
proteins to bind MV particles and to mediate F/H-depen- there was no clear-cut difference in binding between
dent cell–cell fusion. For this, we developed transient CD46 proteins derived from the brains or from HeLa
assays based on mouse Ltk0 cells and the vTF7-3 ex- cells. However, isoforms containing both STP domains
pression system. The MV binding assay was based on bound MV slightly more efficiently than isoforms con-
the method described by Naniche et al. (1993). As a taining only the C domain (averages: BC isoforms, 117%;
negative control, cells were transfected with a plasmid C isoforms, 44%).
containing the CD46 open reading frame in reverse ori- In the next step, we analyzed the ability of the CD46
entation. proteins to confer membrane fusion to mouse L cells. In
a modification of a previously described fusion assayFigure 3 shows an example of this analysis for a C2
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TABLE 2
Properties of CD46 Proteins Derived from HeLa Cells and Human Brains
Source HeLa cells Brain A Brain B Brain C Brain D
Isoform clone BC1 BC2 C1 C2 BC2 C2 C2 C2a BC2 BC2 C2a BC2 C2 C2
11 22H 14 2 84 91 20 92 29 22 73 40 36 63
Surface expressionb 100 55 150 135 90 120 55 50 100 60 30 110 110 105
Binding efficiencyc 100 95 25 27 160 90 73 36 127 73 90 145 36 73
Fusiond / / // // / // / /// / / // / / //
a Clone contains frameshift mutation.
b Surface expression was determined by cytometric analysis and is shown relative to the surface expression of the BC1 form of HeLa cells.
c Binding efficiency: virus binding divided by surface expression. The ratio obtained with the BC1 isoform-encoding plasmid derived from HeLa
cells was set to 100%. The values are averages of two experiments, which differed by 5–30% from the indicated mean.
d Fusion efficiency was determined by counting nuclei in syncytia and total nuclei. /: 5–15% of the nuclei in syncytia; 5–10 nuclei/syncytium.
//: 20–30% of the nuclei in syncytia; 10–30 nuclei/syncytium. ///: 40–60% of the nuclei in syncytia; up to 100 nuclei/syncytium.
(Wild et al., 1991), we cocultivated vTF7-3-infected, CD46- BC isoforms was recently monitored by Iwata et al.
(1994). The B domain thus seems on one hand to inhibittransfected cells with cells infected with a recombinant
vaccinia virus expressing both MV F and H proteins. membrane fusion but on the other hand to increase MV
binding efficiency, a finding which suggests a steric roleSyncytia formation was monitored 20 hr after infection.
In cells transfected with the plasmid coding for a C2 for this part of the molecule.
Evidence suggesting that both STP domains, more pre-isoform about 20% of the nuclei were in syncytia, with
10–30 nuclei per syncytium, whereas only minute back- cisely their O-linked oligosaccharide chains, inhibit fu-
sion results from the functional analysis of the mutantground syncytia were detected when the cells were
transfected with a control plasmid (data not shown). protein of clone 92. This protein, which retains STP C
but has a reduced level of O-glycosylation, is the mostThe results of the fusion assay for all 14 clones used in
the virus binding assay are summarized in the bottom line efficient mediator of membrane fusion despite showing
only moderate efficiency in virus binding. Furthermore,of Table 2. As in the binding assay, clones could not be
distinguished on the basis of their source, but a slight we observed enhanced fusion when the carboxy-terminal
region of CD46, starting with the B domain, was substi-difference in fusion efficiency was observed as a function
of the isoforms analyzed. In general, BC isoforms mediated tuted by immunoglobulin-like, transmembrane, and intra-
cellular domains of the CD4 receptor (C.J.B. and U.membrane fusion less efficiently than C isoforms, in spite
of being more efficient in virus binding. Surprisingly, both Schneider, unpublished results).
The fact that the CD46 proteins from mutated clonesmutant CD46 proteins mediated fusion with high efficiency.
The protein derived from clone 92 was the most efficient 73 and 92, both with a novel cytoplasmic domain, are
very efficient in mediating cell fusion extends the recentmediator of membrane fusion despite being only moder-
ately efficient in binding and surface expression (Table 2). observations demonstrating that the cytoplasmic tail of
CD46 is not required for receptor function (Varior-Krish-
nan et al., 1994; Manchester et al., 1995). The resultsDISCUSSION
obtained with the CD46 protein derived from clone 73
The STP region affects MV binding and virus-induced confirm that SCR IV is not required for MV binding and
fusion cell fusion, as recently demonstrated by Manchester et
al. (1995) and Iwata et al. (1995).Our binding and fusion assays confirmed that the four
isoforms derived from HeLa cells as well as all the brain- CD46 isoform expression in brain and MV
derived CD46 proteins are functional as MV receptors, persistence
in agreement with studies showing that stable cell lines
expressing the four major CD46 isoforms can replicate Our functional studies established that MV-receptor-
competent CD46 proteins are expressed in brain, strength-MV (Manchester et al., 1994; Gerlier et al., 1994). Further-
more, we observed small differences in the MV binding ening the hypothesis that defective MVs which maintained
fusion-competent F and H proteins could spread in theand fusion efficiencies of isoforms containing two STP
domains (BC) and isoforms containing only the C domain. brains of SSPE and MIBE patients via CD46-mediated fu-
sion (Cattaneo and Rose, 1993; Billeter et al., 1994).The former were more active in MV binding while the
latter were more efficient in mediating membrane fusion. Expression of CD46 isoforms is tissue specific and
also a function of the individual genetic background. AIncreased virus-induced fusion in stable cell lines ex-
pressing C isoforms compared to cell lines expressing detailed study on peripheral blood lymphocytes revealed
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Cattaneo, R., and Rose, J. K. (1993). Cell fusion by the envelope glyco-that the BC isoforms predominate in 65% of the individu-
proteins of persistent measles viruses which caused lethal humanals, BC and C are at an equal level in 29%, and the C
brain disease. J. Virol. 67, 1493–1502.
isoforms predominate in 6% of the individuals (Ballard et Do¨rig, R. E., Marcil, A., Chopra, A., and Richardson, C. D. (1993). The
al., 1987). human CD46 molecule is a receptor for measles virus (Edmonston
strain). Cell 75, 295–305.Information about brain CD46 expression is limited
Esolen, L. M., Takahashi, K., Johnson, R. T., Vaisberg, A., Moench,to the study of Johnstone et al. (1993). The predominant
T. R., Wesselingh, S. L., and Griffin, D. E. (1995). Brain endothelialCD46 protein species in autopsy material from six indi-
cell infection in children with acute fatal measles. J. Clin. Invest. 96,
viduals was of the b type (C in our nomenclature), 2478–2481.
and PCR analysis suggested that C2 was the most Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryotic
transient expression system based on recombinant vaccinia virusabundant isoform in all six individuals. Our results
that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad.agree with these observations only in part. We indeed
Sci. USA 83, 8122–8126.observed that the C2 isoform is preferentially ex-
Gerlier, D., Loveland, B., Varior-Krishnan, G., Thorley, B., McKenzie,
pressed, but in addition we cloned cDNA copies of I. F. C., and Rabourdin-Combe, C. (1994). Measles virus receptor
BC2 mRNAs from the three MV-infected brains. Clearly, properties are shared by several CD46 isoforms differing in extracel-
lular regions and cytoplasmic tails. J. Gen. Virol. 75, 2163–2171.as the number of samples analyzed in both studies
Gerlier, D., Varior-Krishnan, G., and Devaux, P. (1995). CD46-mediateddoes not approach statistical significance, this differ-
measles virus entry: A first key to host range specificity. Trendsence might be due to the genotypes of the individuals
Microbiol. 3, 338–345.
analyzed. However, the selective detection of BC iso- Giraudon, P., and Wild, T. F. (1985). Correlation between epitopes on
forms in the three MV-infected brains is intriguing. The hemagglutinin of measles virus and biological activities: Passive
protection by monoclonal antibodies is related to their hemagglutininpossibility that foreign cells preferentially infiltrated the
inhibiting activity. Virology 144, 46–58.MV-affected brains is unlikely because lymphocytes
Griffin, D. E., Ward, B. J., and Esolen, L. M. (1994). Pathogenesis ofexpress both tail 1 and tail 2 isoforms (Post et al., 1991;
measles virus infection: An hypothesis for altered immune re-
Russell et al., 1992). sponses. J. Infect. Dis. 170(Suppl. 1), 24–31.
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